Table 3. . RAS mutation testing turnaround time by data source.
| Data source | Number of samples | Turnaround time (working days), n (%) | ||
|---|---|---|---|---|
| ≤5 | 6–10 | >10 | ||
| Czech Republic I | 100 | 37 (37.0) | 53 (53.0) | 10 (10.0) |
| Czech Republic II | 100 | 43 (43.0) | 47 (47.0) | 10 (10.0) |
| Czech Republic III | 100 | 56 (56.0) | 39 (39.0) | 5 (5.0) |
| Greece | 510 | 0 (0) | 510 (100.0) | 0 (0) |
| Hungary I | 150 | 37 (24.7) | 113 (75.3) | 0 (0) |
| Hungary II | 150 | 46 (30.7) | 73 (48.7) | 31 (20.7) |
| Middle East Pathology I | 447 | 262 (58.6) | 185 (41.4) | 0 (0) |
| Middle East Pathology II | 303 | 274 (90.4) | 29 (9.6) | 0 (0) |
| Middle East Registry | 158 | 33 (20.9) | 61 (38.6) | 64 (40.5) |
| Poland I | 1664 | 1368 (82.2) | 274 (16.5) | 22 (1.3) |
| Poland II | 150 | 27 (18.0) | 71 (47.3) | 52 (34.7) |
| Overall | 3832 | 2183 (57.0) | 1455 (38.0) | 194 (5.1) |